Massachusetts man dies from tick-borne Powassan virus
May 15, 2025
Kevin Boyce, a 62-year-old resident of the Boston area, passed away last year from Powassan virus. Now, his family is raising awareness about the risks of tick bites and urging people to take precautions.
Boyce fell ill in April 2024. Within days, his condition worsened, leading to hospitalization and a diagnosis of Powassan virus, which can cause severe brain inflammation. Despite intensive care, he succumbed to the disease several weeks later.
His family hopes to prevent similar tragedies by encouraging early detection, tick prevention measures, and public awareness. Watch this report from NBC10, Boston.
A federal judge ruled this week that the State of Kansas may proceed with its consumer protection lawsuit against Pfizer in state court, rejecting the pharmaceutical company’s effort to move the case to federal jurisdiction under the Public Readiness and Emergency Preparedness (PREP) Act.
The decision could mark a pivotal moment in efforts to hold vaccine manufacturers accountable for how COVID-19 vaccines were marketed to the public.
In his opinion, U.S. District Judge Daniel D. Crabtree ruled that Kansas’ allegations fall outside the scope of the PREP Act, which grants legal immunity to vaccine manufacturers for injury claims tied to federally recommended pandemic countermeasures. Crabtree found that Kansas’ case centers on claims of deceptive marketing practices, not on physical injuries, and therefore is not preempted by the Act.
“That point alone ends the debate,” Crabtree wrote, concluding the case should be remanded to the District Court of Thomas County, where it was originally filed.
The Kansas Lawsuit
On June 17, 2024, Kansas Attorney General Kris Kobach filed suit against Pfizer, alleging the company violated the Kansas Consumer Protection Act by misrepresenting its COVID-19 vaccine as “safe and effective” while concealing evidence of serious risks and diminishing effectiveness over time. The complaint alleges that:
Pfizer did not disclose links between the vaccine and conditions such as myocarditis, pericarditis, pregnancy complications, and deaths;
The company falsely promoted the vaccine’s continued efficacy even as internal data showed its effectiveness waned;
Pfizer misled the public by claiming the vaccine would prevent transmission of the virus, despite never conducting studies to confirm that claim.
The case does not involve injury or wrongful death claims. Instead, it alleges that Pfizer’s communications misled consumers and violated state law. (See link for article and video)
As many are unfortunately keen to forget, in 2020 the world was locked down for the claim of a deadly pandemic that still only exists in words. We were then coerced into taking an experimental mystery shot that genetically alters us and contaminates us with nanotech. In July of 2020, an accomplished class-action lawyer who beat Volkswagen and Deutsche Bank, Reiner Fuëllmich assembled the Corona Committee to help build a case against those responsible for the greatest crimes against humanity.
For a little over three years, Reiner Fuëllmich and his committee collected interviews and testimony from whistle-blowers, experts, and witnesses up until October of 2023, when he was kidnapped in Mexico, deported to Germany, and detained on allegations of embezzlement. After his arrest, committee member, Viviane Fischer, began publicly attacking Fuëllmich.
A leaked dossier from German intelligence instructed agencies to seize control of the Corona Committee, to silence Reiner Fuëllmich, and to disqualify him from running for public office. (See link for 5 min. video and transcript)
_______________
**Comment**
According to this, “Fuëllmich had been more than an eyesore for large enterprises and the German state for decades…
The corona crisis transformed Fuellmich into a potential three-tiered threat to the official corona narrative and the longer term implementation of the Great Reset. Not only did Fuellmich provide, with CIC, an online platform for scientists and experts critical of the government’s corona narrative voiced their views and scientific findings, he made several attempts to get a class action suit going abroad (in New York, New Zealand, South Africa and twice in Canada) to fight governments’ abuse of human rights, the damage caused by corona measures and more specifically, the use of the PCR-test as a diagnostic tool. His third offensive was political, as the national electoral candidate for the newly established political party, Die Basis, in the run up to the German 2022 elections.”
Fuëllmich simply had to go.
It appears that these agencies got to the committee members and used Fischer to complete their tasks. False allegations of embezzlement and the ensuing negative public opinion paint a starkly different picture than the court hearings. This article gives a overview of the (adjusted) charge.
JVA Rosdorf
Dr. Reiner Fuellmich
Am Grossen Sieke 8
37124 Rosdorf Germany
Letters, cards and postcards are allowed
No glitter on the envelope
No stamps or money in the envelope
Do not send books or any other objects, they will be refused
Do not write about the criminal proceedings against Reiner Fuellmich, although scanning on his incoming post seems to have eased up.
Put your name on each page of your letter and number the pages. If they do check the mail, at least Reiner will know the order of your writing and can see if pages are missing.
Why I Treated Him for Lyme—Even When His Test Was Negative
Posted By: Dr. Daniel Cameron
May 13, 2025
Patients Deserve an Explanation
One of the most common—and most important—questions I hear from patients is:
“If my Lyme test is negative, why are you still treating me?”
It’s a fair question. And if you’re asking it, you deserve a clear and compassionate answer. The truth is, when it comes to Lyme disease, test results don’t always tell the full story.
Let’s break down why.
Lyme Disease Testing Isn’t Always Reliable
The standard test used to diagnose Lyme disease is called the two-tier system. It includes an ELISA screening test followed by a Western blot if the first result is positive. But this system is far from perfect—especially when the infection is in its early or late stages.
Here’s what you should know:
Early in the infection, your body may not have produced enough antibodies yet to trigger a positive result
Some patients never produce detectable antibodies at all
Co-infections like Babesia or Bartonella are not picked up by this test
Many rashes don’t appear in the textbook “bulls-eye” pattern—or don’t appear at all
So yes—you can absolutely have Lyme disease, even if your test is negative. And unfortunately, this is more common than many realize.
In Medicine, We Don’t Wait for Disease to Get Worse
In most areas of healthcare, we don’t wait for a serious event before we start treatment.
We don’t wait for a stroke to treat high blood pressure
We don’t wait for vision loss to manage diabetes
We don’t wait for full organ failure to address chronic kidney disease
We act early—because we know that early treatment improves outcomes. So why does Lyme disease often get treated differently?
When it comes to Lyme, many patients are told to “wait and see”—even when the symptoms are clear and distressing.
Waiting Is Not a Neutral Decision
Here’s what I tell my patients: Waiting is not harmless. It’s a medical decision with consequences.
Delaying treatment can allow symptoms to worsen. It can allow the infection to persist or spread. In some cases, patients who were told to wait eventually end up with a label: Post-Treatment Lyme Disease Syndrome (PTLDS)—a condition where symptoms linger long after the initial infection was treated, or in some cases, never properly treated at all.
What if we had treated earlier? Could we have prevented months—or even years—of suffering?
In many cases, the answer is yes.
Clinical Judgment Is Not Guesswork
When I decide to treat someone for Lyme disease despite a negative test, it’s not a random decision. It’s based on:
• The full pattern of your symptoms
• Your medical history
• Your response to prior treatments
• Known or likely tick exposure
• And experience with thousands of Lyme patients
This is called clinical judgment. It’s a core part of good medical practice. I don’t ignore science—I apply it in context. Because Lyme doesn’t always follow the rules, and neither should we when those rules are failing real people.
You Know When Something Feels Wrong
I’ve met patients who’ve been told their symptoms are “just stress” or “hormonal” or “all in their head.” But they know their bodies. They’ve tracked their fatigue, their joint pain, their cognitive changes. They’ve seen something shift—and they’re right to speak up about it.
Many of those patients improve once treatment begins, even if their test results never confirmed the diagnosis. That’s not luck. That’s Lyme disease showing up in real life—even when it doesn’t show up in the lab.
It’s Time to Rethink How We Treat Lyme
We’re in a new era of medicine. Patients are more informed, more proactive, and more in tune with their own health than ever before. But too often, our Lyme diagnostic standards are stuck in the past—waiting for certainty while people lose months or years of their lives to untreated illness.
We need to bring clinical judgment back into focus. We need to listen more, wait less, and treat Lyme disease with the urgency it deserves.
Final Thoughts
If you’ve been told your test is negative, but you’re still struggling with symptoms—please know this:
You’re not imagining it. You’re not overreacting. And you’re not alone.
In my practice, I treat the whole patient—not just the lab result. Because when it comes to Lyme, early treatment can change everything.
Want to learn more? Follow my blog series for more insights on Lyme disease diagnosis and care—or reach out to my office if you’re looking for answers.
You deserve to be heard.
A very needed article with crucial information for all to understand.
Testing for Lyme/MSIDS is abysmal. Clinical judgement is required; however, doctors receive little training for tick-borne infections and whatever training they do receive is antiquated and biased. The fact the needle hasn’t budged in 40 years is proof of this fact.
Due to the horrific lack of education on all things Lyme/MSIDS, there is a parallel group to the tyrannical IDSA (Infectious Diseases Society of America) called ILADS (International Lyme and Associated Diseases Society) which holds their own medical conferences to educate doctors on what is happening in reality with Lyme/MSIDS and through independent, global research that the IDSA simply ignores or maligns. Their next conference, “The Complexity of Lyme: Diagnosing and Treating Tick-Borne and Related Diseases,” is June 7-8 in Philadelphia.
Our conference will include:
Introduction to diagnosing and treating vector-borne diseases
Case discussions with experts
Advanced topics in clinical treatments such as PANS/PANDAS, Mold toxicity, MCAS, supportive natural therapies and more.
Exhibitors showcasing medical services
CME credit available
The conference is open to healthcare professionals. Students enrolled in a medical degree program and PhD candidates conducting Lyme-related research are also eligible to attend and qualify for discounted rates. Email conference@ilads.org for more information.
The IDSA’s Post Treatment Lyme Disease Syndrome was not good enough!
Carl Tuttle
Hudson, NH, United States
May 15, 2025
The IDSA’s Post Treatment Lyme Disease Syndrome was not good enough so now we have yet another distraction avoiding the elephant in the room (chronic Lyme) called Lyme IACI; “Lyme Infection-Associated Chronic Illness.”
That should add another decade to the denial of chronic Lyme allowing the pharmaceutical industrial complex to roll out its Lyme vaccine and payouts in the form of patent royalties to all those responsible for this crime against humanity. It was that rush to create a vaccine early in the discovery phase of the epidemic that led to the deliberate mishandling of the disease. All the eggs were put into the vaccine basket before a cure was researched and uncovered. We have been dealing with an antibiotic resistant/tolerant superbug but the vaccine money grab was far too lucrative to pass up. Covid proved to us all that our Public Health Officials will do or say anything for the sake of a vaccine; “Safe and Effective“??????
Please take a moment to read the following inquiry sent to Marcia McNutt, President of the National Academy of Sciences regarding a recent publication referencing the latest acronym “Lyme IACI.”
From: CARL TUTTLE <runagain@comcast.net>
To: “mmcnutt@nas.edu” <mmcnutt@nas.edu>, “vdzau@nas.edu” <vdzau@nas.edu>
Cc: “wkearney@nas.edu” <wkearney@nas.edu>, “dmay@nas.edu” <dmay@nas.edu>, “amacdonald@nas.edu” <amacdonald@nas.edu>
Date: 05/14/2025 8:50 AM EDT
Subject: The National Academies Press; Charting a Path Toward New Treatments for Lyme Infection-Associated Chronic Illness
President of the National Academy of Sciences and Chair of the National Research Council
“Most of my current activity centers around meta science – how to shape the culture and conduct of science to build trust, excellence, inclusiveness, and integrity.” – Marcia McNutt
Dear Marcia McNutt,
After reading through your Biosketch you seem to have the capability to detect scientific fraud. Would suppressing evidence of antibiotic resistance (for the sake of a vaccine) constitute a crime? Please take a moment to read the following inquiry addressed to Grace E. Marx, MD Medical Epidemiologist, Centers for Disease Control and Prevention. If the scientific references/evidence I provide were not suppressed the focus would have been on finding effective antimicrobials to treat this antibiotic resistant/tolerant superbug.
Question: Has the National Academy of Sciences under your direction just had the wool pulled over their eyes?
A response to this inquiry is requested.
Carl Tuttle
Independent Researcher
Hudson, NH
Cc: Victor J. Dzau President, National Academy of Medicine
William Kearney Executive Director of the Office of News and Public Information
David May Director, National Academies Press
Alphonse MacDonald Publisher, National Academies Press
Inquiry to: Grace E. Marx, MD Medical Epidemiologist, Centers for Disease Control and Prevention
———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “grace.marx@cuanschutz.edu” <grace.marx@cuanschutz.edu>, “gmarx@cdc.gov” <gmarx@cdc.gov>
Cc: “katrina.rouse@usdoj.gov” <katrina.rouse@usdoj.gov>, “jonathan.kanter@usdoj.gov” <jonathan.kanter@usdoj.gov>
Date: 10/25/2024 9:11 AM EDT
Subject: Tick-Borne Diseases and Associated Illnesses, Community Engagement Series: Mental Health and Neurological Effects
3:00 pm – 3:20 pm A Clinician Toolkit: Improving Care for Patients with Prolonged Symptoms and Concerns about Lyme Disease By Grace E. Marx, MD Medical Epidemiologist, Centers for Disease Control and Prevention
Dear Dr. Marx,
I listened to your presentation yesterday with great interest and I must congratulate you for your outstanding performance in suppressing all evidence of persistent infection; chronic Lyme disease.
We have studies proving persistent infection after antibiotic treatment for mice, dogs, ponies, monkeys, cows, iris biopsy, and ligamentous tissue but if you perform a simple Google search for the following statement, “There is no convincing scientific evidence that chronic Lyme exists” you will find the top search results are connected to “elements of academic medicine” involved in the denial of the late stage Lyme epidemic.
In 1991 the Lyme disease organism, Borrelia burgdorferi, was grown from the cerebrospinal fluid of Lyme patient Vicki Logan at the Centers for Disease Control in Fort Collins, Colorado despite prior treatment with intravenous antibiotics.The patient died when the insurer refused additional IV antibiotics. Here is a copy of Logan’s CDC positive culture report for your review.
There are 700 peer-reviewed publications referencing persistent infection and in a 2018 studyall patients were culture positive even after multiple years on antibiotics so there was no relief from current antimicrobials. Some of these patients had taken as many as eleven different types of antibiotics.
Thirty-four years ago Dr. Allen Steere identified chronic Lyme disease which should have set off a red flag prompting an immediate search for better antimicrobials but then did a 180° as he became principal investigator (PI) of the Phase 3 clinical trial for the first Lyme disease vaccine. So all the eggs were put into the vaccine basket while a campaign was orchestrated to discredit the sick and disabled patient population along with the courageous clinicians attempting to help these patients. Apparently, a chronic relapsing seronegative disease did not fit the business model of patent royalties, vaccine development and pharmaceutical profits.
Here is Dr. Steere’s 1990 publication summary for your review:
The chart below summarizes Lyme research funded by the NIH and only 2.5% has been allocated for treatment:
[Click on the link above to view the chart]
For the record there are many infections requiring long-term antibiotics so why Klempner stopped his NIH funded antibiotic treatment trials for Lyme after 90 days makes absolutely no sense whatsoever:
[Download the article and View Table 4 as there are nine infections listed]
Lyme misdiagnosed/undiagnosed for months, years or decades is far more incapacitating than “acute” Lyme and 2-4 weeks of antibiotics does not scratch the surface of this well-established/immune suppressive infection. These are the patients who need help the most but have been excluded in research for decades. There are countless stories of patients seroconverting after the initial few doses of Doxycycline and now that a toxin has been identified that puts Lyme disease in an altogether different category of infection:
So it would appear that one way to get a medical association (AMA) to go along with the suppression of evidence is to throw them a boatload of money… five million taxpayer dollars to be exact for a so-called IDSA biased “Clinician Toolkit” (CDC grant number NU50CK000597)
This controlling of the narrative has caused unimaginable pain and suffering all across America as insurance companies refuse to pay for long-term treatment, personal bankruptcies from out-of-pocket expenses to treat chronic infection, suicides from despair all while Valneva Received FDA Fast Track Designation for its Lyme Disease Vaccine.
Chronic Lyme must be recognized and finally addressed with 100% attention to effective antimicrobials for all stages of disease.
Question:
Is collusion to control the narrative through suppression of the truth, facts and scientific references a criminal offense?
Carl Tuttle
Hudson, NH
Cc: Assistant Attorney General Jonathan Kanter, Attorney Katrina Rouse
Attorneys for the United States Antitrust Division
“Every year, Americans spend trillions of dollars on health care, money that is increasingly being gobbled up by a small number of payers, providers and dominant intermediaries that have consolidated their way to power in communities across the country,” said Assistant Attorney General Jonathan Kanter of the Justice Department’s Antitrust Division. “Led by Katrina Rouse, the task force will identify and root out monopolies and collusive practices that increase costs, decrease quality and create single points of failure in the health care industry.”
2nd email sent to Marcia McNutt:
———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “mmcnutt@nas.edu” <mmcnutt@nas.edu>, “vdzau@nas.edu” <vdzau@nas.edu>
Cc: “wkearney@nas.edu” <wkearney@nas.edu>, “dmay@nas.edu” <dmay@nas.edu>, “amacdonald@nas.edu” <amacdonald@nas.edu>
Date: 05/15/2025 9:14 AM EDT
Subject: Re: The National Academies Press; Charting a Path Toward New Treatments for Lyme Infection-Associated Chronic Illness
Dear Marcia McNutt,
Please see the inquiry below addressed to Dr. Raymond Dattwyler …..
Dr. Raymond Dattwyler owns 24 patents for Lyme disease that include diagnostic testing and vaccines both live bacteria and oral. Raymond Dattwyler, Benjamin Luft, et al have some interesting comments in their application for a Lyme related patent…
“Currently, Lyme Disease is treated with a range of antibiotics, e.g., tetracyclines, penicillin and cephalosporins. However, such treatment is not always successful in clearing the infection. Treatment is often delayed due to improper diagnosis with the deleterious effect that the infection proceeds to a chronic condition, where treatment with antibiotics is often not useful. One of the factors contributing to delayed treatment is the lack of effective diagnostic tools.”
2022 Inquiry to Dr. Raymond Dattwyler:
———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>To: Raymond_Dattwyler@nymc.eduCc: npjvaccines@nature.com, abarrett@utmb.edu, R.W.Titball@exeter.ac.uk, mgomesso@uthsc.eduDate: 01/06/2023 2:46 PM EST
Subject: The year that shaped the outcome of the OspA vaccine for human Lyme disease
Department of Microbiology and Immunology
New York Medical College
Valhalla, NY
Raymond J. Dattwyler, Corresponding Author
Dear Dr. Dattwyler,
I read your manuscript with great interest as you call attention to a treatment-resistant Lyme arthritis with “no evidence of DNA” found in the joints of patients after antibiotic treatment.
For some strange reason however, I could not find the following 1995 publication within your paper identifying treatment-resistant neuroborreliosis:
We report an unusual patient with evidence of Borrelia burgdorferi infection who experienced repeated neurologic relapses despite aggressive antibiotic therapy. Each course of therapy was associated with a Jarisch-Herxheimer-like reaction. Although the patient never had detectable free antibodies to B. burgdorferi in serum or spinal fluid, the CSF was positive on multiple occasions for complexed anti-B. burgdorferi antibodies, B. burgdorferi nucleic acids and free antigen.
In fact, Dr. Dattwyler there seems to be a great deal of “treatment-resistant” evidence published in multiple journals over the past three decades:
Does a chronic relapsing seronegative disease fit the vaccine model? If not, would that, in and of itself, be the hidden reason for denying chronic (treatment-resistant) Lyme disease for almost three decades? In other words, patent royalties and pharmaceutical profits over lifesaving care?
A response to this inquiry is requested.
Carl Tuttle
Hudson, NH
Cc: Alan D.T. Barrett, PhD Editor-in-Chief
Rick Titball, PhD, DSc, Deputy Editor
I had a sinking feeling then that this would amount to nothing but further entrenchment in the old, antiquated and unscientific Lyme narrative. It appears I was correct. I included the old 2014 interview with Willy Burgdorfer, which I repost here, where he states research must be started over at square one because the same people have been doing the research and coming up with the same results – nothing!
Madison Area Lyme Support Group 